Do modifications of nonequimolar assays for total prostate-specific antigen improve detection of prostate cancer?
Semjonow
A
A
Department of Urology, University of Münster, Albert-Schweitzer Strasse 33, D-48129 Münster, Germany. Semjono@uni-muenster.de
Oberpenning
F
F
Weining
C
C
Schön
M
M
Brandt
B
B
De Angelis
G
G
Heinecke
A
A
Hamm
M
M
Stieber
P
P
Hertle
L
L
Schmid
H P
HP
D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D007118:Immunoassay / Q000379:methods; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood* / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000175:diagnosis*; D011485:Protein Binding; D012372:ROC Curve; D011933:Reagent Kits, Diagnostic; D000514:alpha 1-Antichymotrypsin / Q000378:metabolism
D011933:Reagent Kits, Diagnostic; D000514:alpha 1-Antichymotrypsin; D017430:Prostate-Specific Antigen